RECBIO-B(02179) domestic share issuance application documents have been accepted by the China Securities Regulatory Commission.
Ruikang Biotechnology-B (02179) announces that the company is proposing a targeted issuance of domestic shares and related...
RECBIO-B(02179) announced that matters related to the proposed issuance of domestic shares and other related matters have been approved by the temporary shareholders' meeting. The company recently received the "Administrative License Application Acceptance Form" from the China Securities Regulatory Commission (acceptance number: 250162). The China Securities Regulatory Commission has reviewed the application materials submitted by the company and deemed them complete, and has decided to accept the administrative licensing application.
Related Articles

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


